Table 2.
Sensitization from classic chemotherapy and radiation therapy.
| Drug or therapeutic intervention | Mechanism of action | Immune system interaction |
|---|---|---|
| Cyclophosphamide (38) | Alkylating agent | Decreased Treg cells, ultimately stimulating the immune response. |
| Gemcitabine (39) | Pyrimidine antimetabolite | Decreased number of myeloid suppressor cells, with an overall diminished immune system inhibition. |
| Radiation therapy (43–45) | Double-stranded DNA breaks | Increased antigenic release from cancer cell death. Increased pro-inflammatory cytokines, such as interferon release. This association increases antigenic presentation. |